Joffre B Baker

This inventor holds 44 USPTO granted patents and 28 published patent applications, plus 18 CIPO patents and 37 EPO patents, primarily in Gene Expression Profiling. Top assignees: Genomic Health, Inc., Nsabp Foundation, Inc., Bristol-Myers Squibb Compnay. Active years: 2006-2025.

USPTO Granted Patents = 44 (Patent Applications = 28)

% Patents Active = 93.2

CIPO Patents = 18 (Patent Applications = 4)

EPO Patents = 37 (Patent Applications = 46)

Average Co-Inventor Count = 4.6

ph-index = 14

Forward Citations = 803(Granted Patents)

Company Filing History:

Nsabp Foundation, Inc.

patents

1 out of 3,735

Bristol-Myers Squibb Compnay

patents

4. 1 out of 1

Instituto Nazionale Tumori

patent

5. 1 out of 1

Nsabp Foundations, Inc.

patent

6. 1 out of 40

Rush-Presbyterian-St. Luke's Medical Center

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Gene Expression

Cancer Prognosis

Breast Cancer

Renal Cancer

Colorectal Cancer

Chemotherapy Response

Tumor Tissues

Estrogen Metabolism

Predictive Markers

Clinical Outcome

Recurrence Prediction

EGF Receptor Inhibitors

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2025-09-09),

2. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2023-10-03),

3. 11220715 - Gene expression markers for breast cancer prognosis (2022-01-11),

4. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2021-01-12),

5. 10619215 - Prediction of likelihood of cancer recurrence (2020-04-14),

6. 10260104 - Method for using gene expression to determine prognosis of prostate cancer (2019-04-16),

7. 10241114 - Gene expression profiling in biopsied tumor tissues (2019-03-26),

8. 9944990 - Gene expression markers for breast cancer prognosis (2018-04-17),

9. 9605318 - Gene expression markers for predicting response to chemotherapy (2017-03-28),

10. 9551034 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2017-01-24),

11. 8906625 - Genes involved in estrogen metabolism (2014-12-09),

12. 8868352 - Predicting response to chemotherapy using gene expression markers (2014-10-21),

13. 8808994 - Genes involved in estrogen metabolism (2014-08-19),

14. 8741605 - Gene expression markers for breast cancer prognosis (2014-06-03),

15. 8632980 - Gene expression markers for prediction of patient response to chemotherapy (2014-01-21),

Title: The Innovative Journey of Joffre B Baker

Introduction: Joffre B Baker, a talented inventor hailing from Montara, CA (US), has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Joffre B Baker's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge medical device designed to improve patient outcomes.

Career Highlights: With a career spanning over two decades, Joffre B Baker has established himself as a leading figure in the field of technology innovation. His work has been recognized with numerous awards and accolades.

Collaborations: Throughout his career, Joffre B Baker has collaborated with top research institutions, leading companies, and renowned universities to bring his inventions to life. His collaborative spirit has led to the development of groundbreaking technologies that have transformed industries.

Conclusion: Joffre B Baker's passion for innovation and dedication to pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of innovators.